165 related articles for article (PubMed ID: 23121199)
1. Rapid immunostaining in Mohs: current applications and attitudes.
Trimble JS; Cherpelis BS
Dermatol Surg; 2013 Jan; 39(1 Pt 1):56-63. PubMed ID: 23121199
[TBL] [Abstract][Full Text] [Related]
2. Use of physician assistants in Mohs micrographic surgery: a survey of fellowship-trained Mohs micrographic surgeons.
Hyde MA; Hadley ML; Roberson C; Jacobson A; Pappas L; Bowen GM
Dermatol Surg; 2010 Nov; 36(11):1700-3. PubMed ID: 20961351
[TBL] [Abstract][Full Text] [Related]
3. Recent changes in the workforce and practice of dermatologic surgery.
Tierney EP; Hanke CW; Kimball AB
Dermatol Surg; 2009 Mar; 35(3):413-9. PubMed ID: 19175662
[TBL] [Abstract][Full Text] [Related]
4. Mohs micrographic surgery: How ACMS fellowship directors practice.
Casey AS; Kennedy CE; Goldman GD
Dermatol Surg; 2009 May; 35(5):747-56. PubMed ID: 19389108
[TBL] [Abstract][Full Text] [Related]
5. Advances in immunostains used in Mohs surgery.
Stranahan DR; Cherpelis BS; Fenske NA; Glass LF
J Drugs Dermatol; 2010 Jul; 9(7):760-3. PubMed ID: 20677529
[TBL] [Abstract][Full Text] [Related]
6. Mohs tissue mapping and processing: a survey study.
Silapunt S; Peterson SR; Alcalay J; Goldberg LH
Dermatol Surg; 2003 Nov; 29(11):1109-12; discussion 1112. PubMed ID: 14641335
[TBL] [Abstract][Full Text] [Related]
7. Current progress of immunostains in Mohs micrographic surgery: a review.
Thosani MK; Marghoob A; Chen CS
Dermatol Surg; 2008 Dec; 34(12):1621-36. PubMed ID: 19018832
[TBL] [Abstract][Full Text] [Related]
8. Career trajectory and job satisfaction trends in Mohs micrographic surgeons.
Tierney EP; Hanke CW; Kimball AB
Dermatol Surg; 2011 Sep; 37(9):1229-38. PubMed ID: 21806706
[TBL] [Abstract][Full Text] [Related]
9. How many sections are required to clear a tumor? Results from a web-based survey of margin thresholds in Mohs micrographic surgery.
Cartee TV; Monheit GD
Dermatol Surg; 2013 Feb; 39(2):179-86. PubMed ID: 23003667
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Mohs practices in the United States: a recall survey of ACMS surgeons.
Campbell RM; Perlis CS; Malik MK; Dufresne RG
Dermatol Surg; 2007 Dec; 33(12):1413-8; discussion 1418. PubMed ID: 18076605
[TBL] [Abstract][Full Text] [Related]
11. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
[TBL] [Abstract][Full Text] [Related]
12. Errors in the interpretation of Mohs histopathology sections over a 1-year fellowship.
Murphy ME; Brodland DG; Zitelli JA
Dermatol Surg; 2008 Dec; 34(12):1637-41. PubMed ID: 19018831
[TBL] [Abstract][Full Text] [Related]
13. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
14. Perceptions of expertise in cutaneous surgery and cosmetic procedures: what primary care physicians think.
Ibrahimi OA; Bangash H; Green L; Alam M; Armstrong AW; Eisen DB
Dermatol Surg; 2012 Oct; 38(10):1645-51. PubMed ID: 22958115
[TBL] [Abstract][Full Text] [Related]
15. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
16. Factors Deterring the Utilization of Mohs Surgery for Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hocker TLH
Dermatol Surg; 2021 May; 47(5):709-710. PubMed ID: 33905398
[No Abstract] [Full Text] [Related]
17. Mohs micrographic surgery histopathology concordance in fellowship-trained surgeons.
Lane JE; Chiller KG; Baucom MF; Kent DE
J Am Acad Dermatol; 2010 Jan; 62(1):148. PubMed ID: 20082893
[No Abstract] [Full Text] [Related]
18. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
[TBL] [Abstract][Full Text] [Related]
19. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections.
Kimyai-Asadi A; Ayala GB; Goldberg LH; Vujevich J; Jih MH
Dermatol Surg; 2008 Apr; 34(4):498-500. PubMed ID: 18248466
[TBL] [Abstract][Full Text] [Related]
20. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience.
Bhardwaj SS; Tope WD; Lee PK
Dermatol Surg; 2006 May; 32(5):690-6; discussion 696-7. PubMed ID: 16706765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
